stars 1 stars 2 stars 3

Therabel is a privately-owned pharmaceutical company, with a European heritage stretching back to 1945. It is an organization which has achieved extensive international expansion by means of both acquisitions and organic growth. Product portfolio is primarily generated through collaborations with other pharmaceutical companies. Thus, Therabel’s partnered products consistently benefit from the highest level of commitment and focus. Therabel objective is to provide safe and effective therapeutic solutions developed by our partners, making these available to European healthcare professionals and patients through our know-how in market access and commercialization.

Therabel Questions

The Therabel annual revenue was $58.3 million in 2026.

Leo Drennan is the Managing Director - Therabel Healthcare Limited of Therabel.

34 people are employed at Therabel.

Therabel is based in Levallois-Perret, Île-de-France.

The NAICS codes for Therabel are [32541, 3254, 32, 325].

The SIC codes for Therabel are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users